IP Verse

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring - EP3461503

The patent EP3461503 was granted to Biomarin Pharmaceutical on May 11, 2022. The application was originally filed on Apr 11, 2008 under application number EP18205446A. The patent is currently recorded with a legal status of "Revoked".

EP3461503

BIOMARIN PHARMACEUTICAL
Application Number
EP18205446A
Filing Date
Apr 11, 2008
Status
Revoked
Jun 14, 2024
Grant Date
May 11, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CORIPHARMA EHFNov 9, 2022ELKINGTON AND FIFEADMISSIBLE
DIPHARMANov 9, 2022ELKINGTON AND FIFEWITHDRAWN
BETAPHARM ARZNEIMITTELOct 28, 2022HAMM & WITTKOPPADMISSIBLE
SANDOZOct 12, 2022ELKINGTON AND FIFEADMISSIBLE
STADA ARZNEIMITTELOct 5, 2022HAMM & WITTKOPPADMISSIBLE

Patent Citations (47) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCA2420374
DESCRIPTIONEP0079574
DESCRIPTIONEP0191335
DESCRIPTIONEP1757293
DESCRIPTIONJPH0482888
DESCRIPTIONJPH09157270
DESCRIPTIONJPS5921685
DESCRIPTIONUS2002076782
DESCRIPTIONUS2002106645
DESCRIPTIONUS2002187958
DESCRIPTIONUS2003032616
DESCRIPTIONUS2006040946
DESCRIPTIONUS2601215
DESCRIPTIONUS3505329
DESCRIPTIONUS4540783
DESCRIPTIONUS4550109
DESCRIPTIONUS4587340
DESCRIPTIONUS4595752
DESCRIPTIONUS4649197
DESCRIPTIONUS4665182
DESCRIPTIONUS4701455
DESCRIPTIONUS4713454
DESCRIPTIONUS4752573
DESCRIPTIONUS4758571
DESCRIPTIONUS4774244
DESCRIPTIONUS4920122
DESCRIPTIONUS4937342
DESCRIPTIONUS5037981
DESCRIPTIONUS5198547
DESCRIPTIONUS5350851
DESCRIPTIONUS5401844
DESCRIPTIONUS5698408
DESCRIPTIONUS5753656
DESCRIPTIONUS5874433
DESCRIPTIONUS5922713
DESCRIPTIONUS5945452
DESCRIPTIONUS6011040
DESCRIPTIONUS6274581
DESCRIPTIONUS6410535
DESCRIPTIONUS6441038
DESCRIPTIONUS6544994
DESCRIPTIONWO2005049000
DESCRIPTIONWO2005049614
DESCRIPTIONWO2006055511
OPPOSITIONWO2005049000
OPPOSITIONWO2006055511
SEARCHWO2005049000

Non-Patent Literature (NPL) Citations (43) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BASAK et al., Indian J. Pharm. Sci., (20040000), vol. 66, page 827-
DESCRIPTION- CAI et al., Cardiovascular Research, (20020000), vol. 55, pages 838 - 849-
DESCRIPTION- CHATTARAJ et al., Drug Develop. Ind. Pharm., (19960000), vol. 22, page 555-
DESCRIPTION- CHRISTENSEN et al., Gene Therapy, (20000000), vol. 7, pages 1971 - 1978-
DESCRIPTION- CHRISTENSEN et al., Mol. Gent. And Metabol., (20020000), vol. 76, pages 313 - 318-
DESCRIPTION- COLOMBO, Adv. Drug Deliv. Rev., (19930000), vol. 11, page 37-
DESCRIPTION- DAVIS et al., Eur. J. Biochem., (19880000), vol. 173, pages 345 - 351-
DESCRIPTION- "Disorders of tetrahydrobiopterin and related biogenic amines", BLAU et al., The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, (20010000), vol. 2001, pages 1275 - 1776-
DESCRIPTION- FIEGE et al., Molecular Genetics and Metabolism, (20040000), vol. 81, pages 45 - 51-
DESCRIPTION- FUKISHIMA et al., Anal. Biochem., (19800000), vol. 102, page 176-
DESCRIPTION- FUKUSHIMA; NIXON, Anal. Biochem., (19800000), vol. 102, pages 176 - 188-
DESCRIPTION- KIRSCH et al., J. Biol. Chem., (20030000), vol. 278, pages 24481 - 24490-
DESCRIPTION- LEE et al., Drug Develop. Ind. Pharm., (19990000), vol. 25, page 493-
DESCRIPTION- MATSUURA et al., Chem. Lett., (19840000), page 735-
DESCRIPTION- MATSUURA et al., Chem. Lett. (Japan, (19840000), pages 735 - 738-
DESCRIPTION- MATSUURA et al., Heterocycles, (19850000), vol. 23, no. 12, pages 3115 - 3120-
DESCRIPTION- NARUHASHI et al., Pharm Res., (20030000), vol. 19, pages 1415 - 1421-
DESCRIPTION- NOZAWA et al., J. Pharm Sci., (20030000), vol. 92, no. 11, pages 2208 - 2216-
DESCRIPTION- PABON et al., Drug Develop. Ind. Pharm., (19920000), vol. 18, page 2163-
DESCRIPTION- PAL LIU et al., Arts. Cells. Blood. Subs and Immob. Biotech., (20020000), vol. 30, no. 4, pages 243 - 257-
DESCRIPTION- RAJABI-SIABHOOMI et al., J. Pharm. Pharmacol., (19920000), vol. 44, page 1062-
DESCRIPTION- SCHIRCKS et al., Helv. Chim. Acta, (19770000), vol. 60, page 211-
DESCRIPTION- SUGIMOTO et al., Bull. Chem. Soc. Jp, (19750000), vol. 48, no. 12, page 3767-
DESCRIPTION- SUGIMOTO et al., Bull. Chem. Soc. Jp, (19790000), vol. 52, no. 1, page 181-
DESCRIPTION- SUGIMOTO; MATSUURA, Bull. Chem. Soc. Japan, (19750000), vol. 48, no. 12, pages 3767 - 3768-
DESCRIPTION- SUGIMOTO; MATSUURA, Bull. Chem. Soc. Japan, (19790000), vol. 52, no. 1, pages 181 - 183-
DESCRIPTION- VISONTINI et al., Helv. Chim. Acta, (19690000), vol. 52, page 1225-
DESCRIPTION- WHITELEY et al., Anal Biochem., (19840000), vol. 137, no. 2, pages 394 - 6-
OPPOSITION- "Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage /Passage/", Forth W,, Henschler D, Rummel W, Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage, Elsevier GmbH, Munchen, (20050101), pages 42 - 43, XP055973061-
OPPOSITION- " Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage /Passage/", W. Forth, Henschler D, Rummel W, Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage, Elsevier GmbH, Munchen, (20050101), pages 84 - 85, XP055973064-
OPPOSITION- FDA, "Food-Effect Bioavailability and Fed Bioequivalence Studies", Guidance for industry, US , (20021201), pages 1 - 12, XP008138108-
OPPOSITION- FDA, "Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies", Guidance for industry, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, US, US , (20021201), pages 1 - 12, XP008138108-
OPPOSITION- Forth W,, Henschler D, Rummel W, Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage, Elsevier GmbH, Munchen, (20050101), pages 42 - 43, XP055973061-
OPPOSITION- Heyman Sydney, "PEDIATRIC NUCLEAR MEDICINE Gastric Emptying in Children", J Nucl Med, (19980101), vol. 39, pages 865 - 869, XP055974066-
OPPOSITION- Leggett R, "ANNEX C: REVIEW OF TRANSIT TIMES THROUGH MAJOR SEGMENTS OF THE ALIMENTARY TRACT", ICRP, (20060101), pages 203 - 232, ICRP, (20220621), XP055933428-
OPPOSITION- R. LEGGETT, "Review of transit times through major D5 segments of the alimentary tract", ICRP Publication, Amsterdam, (20060000), vol. 100, pages 203 - 232, XP055933428-
OPPOSITION- W. Forth, Henschler D, Rummel W, Allgemeine und spezielle Pharmakologie und Toxikologie, 9 Auflage, Elsevier GmbH, Munchen, (20050101), pages 84 - 85, XP055973064-
OPPOSITION- Zurfluh, M.R. Giovannini, M. Fiori, L. Fiege, B. Gokdemir, Y. Baykal, T. Kierat, L. Gartner, K.H. Thony, B. Blau, N., "Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper", Molecular Genetics and Metabolism, Academic Press, AMSTERDAM, NL, AMSTERDAM, NL , (20051201), vol. 86, doi:10.1016/j.ymgme.2005.09.011, ISSN 1096-7192, pages 96 - 103, XP005197880
OPPOSITION- Zurfluh, M.R. Giovannini, M. Fiori, L. Fiege, B. Gokdemir, Y. Baykal, T. Kierat, L. Gartner, K.H. Thony, B. Blau, N., "Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper", Molecular Genetics and Metabolism, AMSTERDAM, NL , (20051201), vol. 86, doi:10.1016/j.ymgme.2005.09.011, ISSN 1096-7192, pages 96 - 103, XP005197880
OPPOSITION- MUNTAU A C, ET AL., "TETRAHYDROBIOPTERIN AS AN ALTERNATIVE TREATMENT FOR MILD PHENYLKETONURIA", New England Journal of Medicine, The - NEJM, Massachusetts Medical Society, US, US , (20021226), vol. 347, no. 26, doi:10.1056/NEJMoa021654, ISSN 1533-4406, pages 2122 - 2132, XP008064072
OPPOSITION- MUNTAU A C, ET AL., "TETRAHYDROBIOPTERIN AS AN ALTERNATIVE TREATMENT FOR MILD PHENYLKETONURIA", New England Journal of Medicine, The NEJM, US , (20021226), vol. 347, no. 26, doi:10.1056/NEJMoa021654, ISSN 1533-4406, pages 2122 - 2132, XP008064072
OPPOSITION- Donohoe K. J., Maurer A. H., Ziessman H. A., Urbain J.-L. C., Royal H. D., Martin-Comin J., "Procedure Guideline for Adult Solid-Meal Gastric-Emptying Study 3.0", JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY., SOCIETY OF NUCLEAR MEDICINE, NEW YORK, NY., US, US , (20090901), vol. 37, no. 3, doi:10.2967/jnmt.109.067843, ISSN 0091-4916, pages 196 - 200, XP055933440
OPPOSITION- Donohoe K. J., Maurer A. H., Ziessman H. A., Urbain J.-L. C., Royal H. D., Martin-Comin J., "Procedure Guideline for Adult Solid-Meal Gastric-Emptying Study 3.0", JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, US , (20090901), vol. 37, no. 3, doi:10.2967/jnmt.109.067843, ISSN 0091-4916, pages 196 - 200, XP055933440

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents